The microbiome is recognized as a quasi-organ in the human body. In particular, the gut microbiome is correlated with immune function, metabolism, and tumorigenesis. When dysbiosis of the microbiome occurs, this variation may contribute to alterations in the microenvironment, potentially inducing an inflammatory immune response and providing a niche for neoplastic growth. However, there is limited evidence regarding the correlation and interaction between the microbiome and tumorigenesis. By utilizing microRNA sequencing data of patients with colon and rectal cancer from The Cancer Genome Atlas, we designed a novel analytical process to extract non-human small RNA sequences and align them with the microbial genome to obtain a comprehensive view of the cancer-associated microbiome. In the present study, we identified > 1000 genera among 630 colorectal samples and clustered these samples into three distinctive colorectal enterotypes. Each cluster has its own distinctive microbial composition and interactions. Furthermore, we found 12 genera from these clusters that are associated with cancer stages and revealed their putative functions. Our results indicate that the proposed analytical approach can effectively determine the cancer-associated microbiome. It may be readily applied to explore other types of cancer, in which specimens of the microbiome are difficult to collect.
Introduction
The microbiome is a complex community in the human body, which comprises an immense number of microbes. It exhibits delicate interplay with the host activities, such as shaping the immune system, maintaining epithelium homeostasis, and regulating metabolism (1) . The composition of the microbiome in various sites of the human body differs enormously. For example, the principal phyla in the colon and rectum are Firmicutes and Bacteroidetes (2) , while the predominant phyla in breast tissue are Proteobacteria and Firmicutes (3) . When the composition of the microbial community changed, relationship between microorganisms and host may also be altered, which may promote the development of different diseases. For example the involvement of altered microbiome have been reported in asthma (4) , inflammatory bowel disease (5) , and depression and anxiety (6) .
The investigation of cancer-associated microbiome has attracted considerable attention which may lead towards the development of promising new targets in cancer diagnostics and therapeutics. Along with tumor growth, alterations in the composition of the microbiome may augment the severity of the disease and influence the tumor microenvironment (7, 8) . A recent study showed that some bacteria, for instance Mycoplasma hyorhinis, have the ability to modify the structure of gemcitabine to render its anticancer activity (9) . Furthermore, microbes, such as Fusobacterium nucleatum reside adjacent to tumor may affect immune response and severity of cancer (10) .
The 16S rDNA sequencing is the prevalent technique in studying bacteria, which provides researchers a rich source of information to distinguish a myriad of bacteria. The 16S rRNA gene is presented in all bacteria and its function and sequence are preserved through evolution (11) . One of the challenges of using 16S rDNA is its data type which restricts the possibility of using large amount of existing data for example The Cancer Genome Atlas (TCGA) which provides various omics data of different types of cancers. In this report, we proposed a new analytical method for characterizing cancer-associated microbiome using the available small RNA-Seq data from cancer patients (Figure 1 ).
To examine whether our method has the same efficiency of identifying cancer-associated microbiome as 16S rDNA sequencing did on colorectal cancer (CRC) as well as the colon and rectum cancers, we took the CRC small RNA sequencing results from TCGA dataset as the subject of our study. We gathered CRC microRNA sequencing (miRNA-Seq) data from TCGA and applied our proposed method to identify the microbiome in each sample.
We determined > 1,000 genera in 630 samples and obtained similar results as those obtained through 16S rDNA sequencing in previous investigations (8, (12) (13) (14) . The findings demonstrated that our method has a strong capacity to reveal the cancerassociated microbiome in CRC and may also be applied to different types of cancers.
Materials and Methods

Data preparation
CRC miRNA-Seq bam files were collected from the Genomic Data Commons Data Portal (downloaded: September 9, 2018). The files included two categories, namely colon adenocarcinoma (COAD; n = 465) and rectum adenocarcinoma (READ; n = 165) (15) .
The SAMtools (version 1.3.1) were used to extract small RNA reads, which were unmapped to the human genome in the bam files to generate possible reads originating from gut microbiota (16).
Alignment of non-human small RNA reads
After filtering out the reads mapped to human miRNA and genome, we gathered nonhuman small RNA reads for microbiome analysis. The sRNAnalyzer pipeline was used for the alignment of non-human small RNA sequences (17) . sRNAnalyzer is a specialized tool for alignment of small RNAs, which encompasses three procedures, namely "Preprocessing", "Alignment", and "Summarization". Several parameters are required for data preprocessing and alignment. Accordingly, we set the minimum read length to 20 nucleotides, allowed reads to map to multiple reference databases for holistic, and omnibus mapping results, but not allowed any mismatch in order to obtain the highest accuracy of alignment. In the alignment procedure, we utilized the National Center for Biotechnology Information (NCBI) nucleotide database and Human Microbiome Project gastrointestinal database, provided through sRNAnalyzer, as our primary bacterial reference genome (17) . However, we modified the procedure of the sRNAnalyzer after the alignment step and designed a new process customized for microbiome analysis.
Annotation of bacterial small RNA reads
The alignment results was obtained with two Perl scripts (desProfile.pl and taxProfile.pl), which are provided in the sRNAnalyzer selfDev folder, to add information on reads including species taxonomy. The reads mapped to multiple species were assigned to their common taxon. Moreover, when the count table for each taxonomic rank was generated, reads from common taxonomic levels were assigned to a higher level. Therefore, those species-ambiguous reads could be assigned correctly to the right taxonomic ranks.
Data Normalization
Since the microbiota count data contained a considerable number of zeros, we applied geometric mean of pairwise ratio (GMPR), a normalization method for zero-inflated data, to produce the count table (18) . The GMPR normalization method requires two parameters, namely the intersection numbers for the minimum number of shared features and the minimum number of counts. The intersection numbers of the phylum, class, order, family, genus, and species count table were set at 1, 1, 3, 3, 5, and 5, respectively; the minimum number of counts we set was the default value provided by the package.
Co-occurrence between genera
To visualize the bacterial genus co-occurrence network in each cluster, we calculated the relative genus abundance (percentage) in each sample, and selected genera that were detected in ≥ 20% of samples in the cluster. The Pearson correlation coefficient (PCC) was calculated and subsequently Fisher's z-transformation was used to calibrate the PCC according to the sample size in each cluster. The pairs of genera with an absolute value of Fisher's z-transformation ≤ 1.96 was removed. After removing uncorrelated pairs, Cytoscape was used for the computation of topological properties and network visualization (19) .
RNA-Seq expression data
CRC RNA expression data were downloaded from TCGA-COAD and TCGA-READ.
Subsequently, the raw count was normalized with TMM normalization in the edgeR package (version 3.24.3) for cross-sample normalization (20) .
Functional gene set enrichment analysis
To demonstrate what biological processes of tumor cells are probably affected by cancerassociated bacteria, the Spearman correlation coefficient was calculated using the relative abundance of bacteria and patient RNA expression data. The fast pre-ranked gene set enrichment analysis (21) was applied to glean the candidate biological processes using the correlation coefficients as pre-ranked input data. The gene sets of biological processes in terms of Gene Ontology (GO) were downloaded from the Molecular Signatures Database (21, 22) .
Univariate survival analysis
The TCGA-COAD and TCGA-READ patient data were obtained using the R packages RTCGA (version 1.12.1) and RTCGA.clinical (version 20151101.12.0) (23). The survival analysis was conducted using cancer-associated bacteria as the univariate. We combined patient data with genus-relative abundance data, and categorized the samples into high and low sets using the median genus-relative abundance in 630 samples. This was performed using two R packages, namely survival (version 2.44-1.1) and survminer 9 (version 0.4.3) (24, 25) .
Statistical analysis and data visualization
The R package vegan (version 2.5-4) was used for Shannon diversity and evenness analysis (26) . Heatmaps were produced using the R package ComplexHeatmap (version 1.99.7) (27) . Both the Kruskal-Wallis test and Mann-Whitney U test, shown as box plots, were performed using the R package ggpubr (version 0.2) (28). The networks was analyzed and computed their topological properties using Cytoscape (version 3.7.1) (19) .
Only the top 15 positive and negative correlations according to their Fisher Ztransformation value were depicted.
Results
Identification of CRC microbiota
To explore the microbiota associated with CRC ( Figure 1 ), we mapped non-human small RNA reads against data from two microbial reference databases, namely the National Center of Biotechnology Information (NCBI) bacteria nucleotide and the National Institutes of Health (NIH) Human Microbiome Project. Approximately 626,084 unique small RNA sequences were aligned with those of microbial reference genomes, and ≤ 55.4% of the sequences aligned to specific genera or species. About 20% of the reads could be mapped to a myriad of bacteria from different phyla; thus, those sequences were excluded from further analysis. To ensure that the count data were not biased due to different library size in each sample, the raw count data was consequently calibrated using GMPR (18), a specialized normalization method for zero-inflated data like microbiome sequencing data, to produce the count table at each taxonomic rank.
Composition of the microbiome in colorectal cancer
The relative abundance of phyla within the tumor and adjacent normal tissues was investigated to determine the phylogenetic composition of the microbiome in colorectal cancer (Figure 2A, B ). The three predominant phyla identified were Firmicutes, Bacteroidetes, and Proteobacteria, which are the prevailing phyla in the human gut microbiota (29) . The fourth and fifth most abundant phyla were Actinobacteria, and Fusobacteria, respectively. Fusobacteria were highly enriched in tumor tissues ( Figure   2B ), as shown by previous studies (10, 30, 31) . Fusobacterium nucleatum, one of species in the Fusobacteria phylum, is usually detected in CRC and has the ability to generate a proinflammatory microenvironment (10, 30) . In the current study, Fusobacterium nucleatum also had higher abundance in tumor samples (Supplementary Figure S1C ). Furthermore, Fusobacterium was the third most abundant genus in 630 samples analyzed in the current study (Supplementary Figure S1A) . Compared with previous research on the healthy gut microbiome (29) , several of the reported genera were also found in our analysis. However, their relative abundance and the order of genera abundance were different. These findings demonstrated that several genera may correlate with CRC based on their abundance differences with the normal tissues.
The human gut microbiota is affected by diet, age, and other factors, resulting in a distinctive gut microbiota in each individual (32) . The spectrum of bacterial phylum in all samples analyzed in the study is presented in Figure 2D and the results showed unique composition for each individual. The samples were then grouped into 3 clusters, Cluster_Bac, Cluster_Fuso, and Cluster_Pro, based on relative phylum abundance using spherical k-means. The box plots, t-distributed stochastic neighbor embedding (t-SNE; Figure 2C ), as well as principle component analysis (Supplementary Figure S2 ) were used to illustrate microbiome composition differences among the three clusters. The names of these clusters were derived from the most abundant phylum identified in each cluster ( Figure 2E ; Supplementary Figure S3 ). To examine whether the clustering results were affected by the location of cancer (colon vs. rectum), the t-SNE results was replotted based on cancer location (Supplementary Figure S1B ). TCGA-COAD and TCGA-READ were evenly distributed in the t-SNE plot, which suggested the clustering results were influenced by bacterial compositions rather than cancer location. We observed the differences in Shannon-diversity and evenness index between the three clusters ( Figure   2F ). Cluster_Pro exhibited the highest diversity and the most genera abundance distributed evenly in predominant genera compared to other clusters. Interestingly, the patients' guts that was highly enriched with Fusobacteria, Cluster_Fuso showed the lowest diversity and evenness in their microbiomes. However, the high abundance of
Fusobacteria did not show a strong correlation with cancer stage (Table 1) .
Since the differences in the phylum composition observed in the three clusters, we constructed genus co-occurrence networks ( Figure 3A -C) and heatmaps (Supplementary Figure S4A -C). We further determined the topological properties of each genus to gather more evidence regarding the interplays of genera ( Supplementary Table S1 -3). Due to the complex correlation in the full co-occurrence network, only the top 15 positive and negative correlations based on their Fisher Z-transformation values were showed in Figure 3 . These networks illustrated that each sample cluster exhibited distinctive bacterial interplay and different hub genera. For instance, Bacteroides had the third highest network degree in the Cluster_Bac co-occurrence network ( Supplementary Table   S1 , Figure 3A) , and the highest betweenness centrality. This indicated that Bacteroides played an important role that might affect other genera and acted as a hub in this network.
In the Cluster_Fuso co-occurrence network ( Supplementary Table S2 , Figure 3B ), although Fusobacterium did not have the highest network degree, Fusobacterium had several strong correlations in the network, indicating that Fusobacterium is also a hub in the co-occurrence network.
Detection of cancer-associated bacteria
To detect cancer-associated bacteria, we first selected common bacterial genera which were detected in ≥ 20% of the samples. The genus-relative abundance in normal tissues adjacent to tumors in the three clusters were compared and calculated. More than 50 genera with differential abundance in cancer were observed (Supplementary Figure S5) .
The 25 genera previously reported as cancer-associated bacteria were used to examine the consistency of our results with other studies (Figure 4) (7, 8, (12) (13) (14) 31, (33) (34) (35) (36) (37) . Several genera, such as Porphyromonas, Roseburia, Ruminococcus, Subdoligranulum, Bacterodies, and Prevotella, were reportedly increased as well as decreased in CRC;
hence, we classified these genera in an ambiguous category.
In the category of over-represented bacteria in the cancer-associated microbiome, the abundance of Fusobacterium, Streptococcus, Veillonella, Haemopilus, Bilophila, Acinetobacter, Phascolarctobacterium, Akkermansia, Escherichia, Enterococcus, Parvimonas, and Anaerococcus was consistent with previous studies (12, 14, 33, 34, 37) .
However, in Cluster_Fuso these showed lower abundance compared to normal samples.
In the under-represented category, a portion of the genera in Cluster_Bac and Cluster_Pro showed higher abundance than normal samples. According to the complete patient clinical data, the correlations between bacterial genus abundance and different cancer stages were observed. Both Dorea and Blautia showed a tendency toward decreasing abundance along with an advanced cancer stage, despite having a higher average abundance than normal samples. Twelve genera including Dorea, Faecalibacterium, Roseburia, Pseudoflavonifractor, Sutterella, Pseudomonas, Blautia, Faecalitalea, Bacteroides, Subdoligranulum, Amycolatopsis, and Desulfovibrio were considered cancer stage-associated bacteria in different clusters ( Figure 5 ). Most of the cancer stageassociated genera, such as Dorea, Roseburia, and Blautia, exhibited a tendency of decreasing abundance along with advanced cancer stage. Only three genera, Faecalitalea, Amycolatopsis, and Desulfovibrio, showed higher abundance in stage IV cancer.
Biological functions correlate with cancer-associated bacteria
The finding of cancer stage-associated microbiome population allows us to explore the relationships between bacterial abundance and tumor progression, and the possible influence of microbiome on host in terms of the perturbed biological processes. The correlation between bacterial genera abundance and mRNA gene expression was calculated using the Spearman correlation coefficient, and applied pre-ranked gene set enrichment analysis methods to identify the enriched biological processes influenced by cancer stage-associated bacteria. The top 50 most representative enriched biological processes (in GO terms) were selected and displayed their enrichments in different cancer-associated bacteria in Figure 6 . Among these functions, immune responses (i.e., leukocyte activation, leukocyte degranulation, regulation of the T-cell receptor signaling pathway, etc.) were highly correlated with the cancer stage-associated microbiome.
Moreover, several metabolic processes (i.e., fatty acid and carbohydrate catabolic processes, oligosaccharide metabolic process, etc.) were also related to the cancerassociated microbiome. These results provided a holistic picture of plausible effects caused by the microbiome and need to be scrutinized by additional studies.
Correlation between bacteria and patient survival
Survival analysis was conducted to explore whether cancer stage-associated bacteria were correlated with patient survival. The patients were into high-and low-abundance groups according to the cancer stage-associated microbiome, and found that four genera (Dorea, Blautia, Subdoligranulum, and Sutterella) had a strong correlation with patient survival.
Higher relative abundance of those bacteria was associated with better survival ( Figure   7 ). A previous study showed that Blautia in the gut microbiome might reduce mortality from graft-versus-host disease (38) . Therefore, these four genera may provide new targets for the treatment of patients with poor prognosis.
Discussion
A novel analytical approach was developed and used to demonstrate the possibility of using the small RNA sequencing data to study cancer-associated microbiome. This approach provided results, which were similar to those reported in previous studies using 16s rDNA sequencing (7, 8, (12) (13) (14) 31, (33) (34) (35) (36) (37) . We utilized non-human miRNA reads extracted from TCGA-COAD and TCGA-READ miRNA-Seq data. These miRNA-Seq data were directly collected from tumor and adjacent normal tissues (39) . After extracting non-human small RNA reads, we performed sequence alignment against various bacterial sequence databases with multiple stringent parameters to yield more accurate results, and filtered out unqualified reads during alignment. Owing to the fact that short reads may be mapped to multiple species, we considered all possible results and annotated those reads with their joint taxonomic rank. In addition, approximately half of the reads that mapped to several phyla were excluded, and the remaining reads which could be identified in certain taxonomic ranks except phylum. This step is similar to the construction of operational taxonomic unit clusters using sequence similarity in 16s rDNA sequencing analysis (40) .
The 16s rDNA sequencing is based on DNA so each bacterium has one copy; however, small RNA sequencing is based on RNA and each bacterium will have many copies.
When growth condition is better, the levels of rRNA and mRNA in bacteria can be even higher. In theory, the RNA-based measurement can provide better picture of bacteria composition due to amplification of the signal from one copy (DNA) to thousands or millions copies (RNA); however, the amplification process may skew the composition since it favors the bacteria that are growing. Nevertheless, the results showed some similarities between the two platforms, suggesting that the dominate signal (composition) is faithfully "translated" from DNA to RNA but for weaker signals, the RNA might work better. In addition, the RNA-based measurement may also reflect the activity of the bacteria community -the less representing groups (in RNA-based measurement compared to DNA-based measurement) may be less active.
The five most abundant phyla in both tumor and adjacent normal tissues identified in this study (Figure 2A, B) were in agreement with previous findings (7, 10, 30, 31) . One of phyla, Fusobacteria, was highly enriched in tumor tissues (7, 10, 30, 31) . The results indicated that Fusobacteria prefer to inhabit tumor tissues rather than adjacent normal tissues (10) .
Moreover, that the results showed that each patient had a distinctive microbiome composition ( Figure 2D ) in tumor tissues, which might be affected by diet, drug treatment, age and disease stage. The differences of microbiome composition might produce unique microenvironments which correlate with host biological functions (1) . Based on the spectrum of microbiome, the samples can be classified into three major clusters, namely Cluster_Bac, Cluster_Fuso, and Cluster_Pro ( Figure 2E ) using spherical k-means method .
The adjacent normal tissues were collected from sites near tumors; therefore, those tissues would have the parallel dominant microbes as the tumor tissues. However, there is a small portion of microbes changed their abundance in tumor as well as different tumor stages, which probably caused by the inter-species competition in the tumor microenvironment ( Figure 4-5; Supplementary Figure S5 ). The findings of cancer-associated microbiome through mining small RAN sequencing data are similar to prior reports (Figure 4) (7, 8, (12) (13) (14) 31, (33) (34) (35) (36) (37) . Interestingly the genera in Cluster_Fuso exhibited different pattern from previous studies (8, 13, 33, 41, 42) . Fusobacteria were highly abundant in Cluster_Fuso, and the genus Fusobacterium negatively correlated with other genera (Figure 3 and Supplementary Figure S3B ). Therefore, genus representation in Cluster_Fuso may differ from comparing with that reported in previous studies (7, 8, (12) (13) (14) 31, (33) (34) (35) (36) (37) . Dorea and Blautia had higher abundance in Cluster_Bac and Cluster_Pro and the abundance of them declined in parallel with advancing cancer stage ( Figure 5) . These results were also consistent with previous studies (8, 12, 33, 41, 42) .
Based on large-scale cohort studies and meta-omics resources from the TCGA, several techniques were applied to examine the correlation between the cancer-associated microbiome and biological functions in tumors. There is one caution of using small RNA sequencing data for microbiome analysis, which is short read length. Due to their short length, an immense amount of reads could be aligned to multiple species, and only part of the reads could be assigned to unique species. This limited the taxonomic resolution of the analysis. Nevertheless, in the taxonomic rank of genera, genus count data could provide a sufficient amount of reads for further analysis steps, and higher taxonomic ranks may yield more robust results.
In conclusion, this method provides a simple and robust approach for analyzing the cancer-associated microbiome based on small RNA sequencing data and the findings are similar to those obtained using the 16S rDNA method. Currently, colonization of numerous body sites by the microbiome has been reported, and an increasing number of studies are being conducted to investigate the association between cancer and the microbiome. Our method can be applied to different types of cancers and utilized results from large-scale cohort studies (e.g., using TCGA data) to identify links between patient variables and microbiome. This diagram illustrates the analysis procedures, including input data, tools used, and critical processes during analysis. The diagram also provides several crucial parameters which is required for the sRNAnalyzer pipeline to yield more accurate alignment results. 
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